6Kimura H, Tizasa T, Ishikawa A, et al. Prospective phase Ⅱ study of post-surgical adjuvant chemoimmunotherapy using autologous dendritic cells and activated killers cells from tissue culture of tumor-draining lymph nodes in primary lung cancer patients [J]. Anticancer Res, 2008,28 (2B) : 1229 - 1238.
7Hirschowitz EA, Foody T, Hidalgo GE, et al. Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cells [ J ]. Lung Cancer, 2007, 57 (3) : 365 - 372.
8Babatz J, Rollig C, Lobel B, et al. Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells[J ]. Cancer Immunol Immunother, 2005, 54 (2) : 1 - 9.
9Kashiwabara K, Saeki S, Sasaki J, et al. Combined evalution of postoperative serum levels of carcinoembryonic antigen less than or equal to 2.5 ng/ml and absence of vascular invasion may predict no recurrence of stage Ⅰ adenocarcinoma lung cancer [ J ]. J Thorac Oncol, 2008, 3 (12) : 1416 -1420.
10Seliger B. Strategies of tumor immune evasion [ J ]. Biodrugs, 2005, 19(6) : 347-354.
4Ilett E J, Prestwich RJ, Melcher AA. The evolving role of dendritic cells incancer therapy[ J]. Expert Opin Biol Ther,2010,10 ( 3 ) : 369 - 379.
5Niam M, Linn YC, Fook Chong S, et al. Clinical scale expansion of cytokine- induced killer cells is feasible from healthy donors and patients with acute and chronic myeloid leukemia at various stages of therapy[J]. Exp Hematol,2011,39(9) :897 -903.
6Wongkajornsilp A, Somchitprasert T, Butraporn R, et al. Human cy- tokine - induced killer cells specifically infiltrated and retarded the growth of the inoculated human eholangiocarcinoma cells in SCID mice[ J]. Cancer Invest,2009,27 (2) : 140 - 148.
8Olioso P, Giancola R, Di Riti M, et al. Immunotherapy with cytokine inducedkiller cells in solid andhematopoietic tumours:A pilot clini- caltrial [ J ]. Hematol Oncol,2009,27 ( 3 ) : 130 - 139.
9Parashar B,Edwards A, Mehta R, et al. Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer[J]. Am J Chin Oncol, 2011,34(2): 160-164.
10Li H,Yu JP, Cao S,et al.CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients[J].J Clin Immunol, 2007,27(3):317-326.
